Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 285 of 285 entries
View as:

To Evaluate the Efficacy and Safety of TQB3728 Tablets in Sequential Maintenance of TQB2450 Injection Therapy in Patients After Sequential or Concurrent Chemoradiation for Locally Advanced Non-small Cell Lung Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT05859373 Org: User:
Start: 06/30/23 End: 12/31/24 Due: 12/31/25

A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04836663 Org: User:
Start: 04/23/21 End: 12/30/22 Due: 12/30/23

A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05913089 Org: User:
Start: 06/14/23 End: 12/31/26 Due: 12/31/27

A Clinical Trial to Evaluate the Efficacy and Safety of TQA3605 Tablets in Treatment-naive Chronic HBV-infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06990776 Org: User:
Start: 05/31/25 End: 09/30/28 Due: 09/30/29

Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05780567 Org: User:
Start: 03/30/23 End: 01/31/27 Due: 01/31/28

TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05563480 Org: User:
Start: 10/27/22 End: 05/31/24 Due: 05/31/25

A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab Injection Combined With Chemotherapy in First-line Treatment of Relapsed/Metastatic Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05783921 Org: User:
Start: 05/23/23 End: 01/31/25 Due: 01/31/26

Evaluate the Efficacy and Safety of TQC2731 Injection in Patients With Severe Asthma.

Phase: N/A Priority: Normal
NCT ID: NCT05472324 Org: User:
Start: 09/23/22 End: 10/31/24 Due: 10/31/25

Study of TQB2450 Combined With Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）

Phase: N/A Priority: Normal
NCT ID: NCT03910127 Org: User:
Start: 06/11/19 End: 06/30/21 Due: 06/30/22

A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)

Phase: N/A Priority: Normal
NCT ID: NCT04344158 Org: User:
Start: 08/11/20 End: 12/31/26 Due: 12/31/27